Cite
HARVARD Citation
Wang, J. et al. (2020). A77 1726, the active metabolite of the anti‐rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases. FASEB journal. 34 (8), pp. 10132-10145. [Online].